Europe Medical Cannabis Market – Industry Trends and Forecast to 2030

Pharmaceutical
Published Report
May 2023
Europe
350 Pages
No of Tables: 1192
No of Figures: 51

Report Description
Table of Content
List of Table
List of Figure

Europe Medical Cannabis Market, By Product (Oil, Medical Cannabis Capsules, Patch, Whole Flower, Ground Flower, Vape Pen, Dried Medical Cannabis, Creams & Moisturizer, Masks & Serum, Cleanser, and Others), Source (Natural and Synthetic), Species (Cannabis Indica, Sativa, and Hybrid), Application (Alzheimer’s Disease, Appetite Loss, Cancer, Inflammatory Bowel Diseases, Eating Disorders, Epilepsy, Autism, Mental Health Conditions, Multiple Sclerosis, Pain Management, Nausea, Muscle Spasms, Wasting Syndrome (Cachexia), Elevate Mood, Depression and Sleep Disorders, Anxiety, and Others), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC)/ Delta-8-Tetrahydrocannabinol, Cannabinol (CBN), Cannabicyclol (CBL), Cannabichromene (CBC), Cannabigerol (CBG), and Others), Treatment Type (Expectorant, Antiviral, Analgesic, Aphrodisiac, Psychedelic, and Others), Route of Administration (Oral Solutions and Capsules, Smoking, Vaporizers, Topicals, and Others), End User (Pharmaceutical Industry, Research and Development Centers, Homecare Setting, Hospital, Rehab Centers, and Others), Distribution Channel (B2B and B2C) - Industry Trends and Forecast to 2030.

Europe Medical Cannabis Market Analysis and Insights

The rising number of patients related to chronic diseases Europe and an increased inclination towards a healthy lifestyle are some of the factors that are expected to drive market growth. In addition, the rise in the number of product approvals and increasing R&D activities for medical cannabis devices are expected to drive market growth. However, the high cost of medical cannabis devices and procedures, medicinal drugs, safety concerns and adverse effects associated with laser procedures, and lack of awareness about the treatment from laser devices are expected to restrain the market growth. Additional technological advancements in medical cannabis and strategic initiatives by emerging players are expected to act as opportunities for market growth. However, stringent regulations and a lack of skilled professionals are expected to pose a challenge to market growth.

The use of cannabis as medicine is not rigorously tested due to government restrictions and resulting in limited clinical research to define the efficacy of cannabis in medical and clinical applications. However, preliminary studies suggest that cannabis reduces vomiting and nausea in chemotherapy patients and helps in increasing appetite.

Data Bridge Market Research analyzes that the Europe medical cannabis market is expected to grow at a CAGR of 22.5% during the forecast period of 2023 to 2030.

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Year

2021 (Customizable to 2015 – 2020)

Quantitative Units

Revenue in USD Million

Segments Covered

Product (Oil, Medical Cannabis Capsules, Patch, Whole Flower, Ground Flower, Vape Pen, Dried Medical Cannabis, Creams & Moisturizer, Masks & Serum, Cleanser, and Others), Source (Natural and Synthetic), Species (Cannabis Indica, Sativa, and Hybrid), Application (Alzheimer’s Disease, Appetite Loss, Cancer, Inflammatory Bowel Diseases, Eating Disorders, Epilepsy, Autism, Mental Health Conditions, Multiple Sclerosis, Pain Management, Nausea, Muscle Spasms, Wasting Syndrome (Cachexia), Elevate Mood, Depression and Sleep Disorders, Anxiety, and Others), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC)/ Delta-8-Tetrahydrocannabinol, Cannabinol (CBN), Cannabicyclol (CBL), Cannabichromene (CBC), Cannabigerol (CBG), and Others), Treatment Type (Expectorant, Antiviral, Analgesic, Aphrodisiac, Psychedelic, and Others), Route of Administration (Oral Solutions and Capsules, Smoking, Vaporizers, Topicals, and Others), End User (Pharmaceutical Industry, Research and Development Centers, Homecare Setting, Hospital, Rehab Centers, and Others), Distribution Channel (B2B and B2C)

Countries Covered

Germany, Italy, U.K., Austria, Poland, Lithuania, Ireland, Netherlands, Norway, Switzerland, France, Russia, Spain, Hungary, Belgium, Turkey, and Rest of Europe

Market Players Covered

MediPharm Labs Inc., Tilray, Aurora Cannabis, JAZZ Pharmaceuticals Inc. (GW Pharmaceuticals plc), HEXO Corp. (Zenabis Europe Ltd), Cresco Labs, Peace Naturals Project Inc., CANOPY GROWTH CORPORATION, Medical Marijuana, Inc., Seed Cellar, EcoGen Biosciences, CANNABIS SEEDS USA, Seeds For Me, HUMBOLDT SEED COMPANY, Extractas, World Class Cannabis Seeds (Crop King Seeds), BARNEY'S FARM, FOLIUM BIOSCIENCES, PharmaHemp, Elixinol Europe Limited, ENDOCA, Harmony, MARY’S nutritionals, LLC, Pure Ratios, Greenwich Biosciences, Inc., Upstate Elevator Supply Co., Apothecanna, BOL Pharma, and IDT Australia among others

Market Definition

Cannabis is a psychoactive drug that is derived from the cannabis plant of the Cannabaceae family. For several years, it has been used medicinally and has a wide range of applications in the treatment of various diseases including chronic pain, cancer, depression, diabetes, arthritis, glaucoma, epilepsy, migraines, AIDS, and Alzheimer’s among others.

The increased medicinal use of cannabis, the controlled legalization and use of cannabis in various industries, and the advanced methodologies present in the field are some of the factors expected to drive market growth.

Europe Medical Cannabis Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail as below:

Drivers

Increased use of cannabis in medicines

Medicinal cannabis is derived from cannabis plants and can be used to treat symptoms of certain medical conditions, and the side effects of some treatments. The most common form of medicinal use of cannabis is pain management. There has been gradual acceptance and use of medicinal cannabis with the growing number of countries that have legalized the use of cannabis for various indications. Medical cannabis has been approved for use by the FDA for three indications which are rare and severe forms of epilepsy, Dravet syndrome, and Lennox-Gastaut syndrome and also to treat the spasticity in Multiple Sclerosis (MS).

Medical marijuana uses the marijuana plant or chemicals in it to treat diseases or conditions apart from the approved drugs, there is an increased interest in two cannabinoids which are delta-9-tetrahydrocannabinol and cannabidiol. Tetrahydrocannabinol is shown to improve appetite, minimize fatigue, and manage muscle function issues while cannabidiol is effective for managing epileptic seizures, curing psychiatric illness, and reducing inflammation.

Legalization of Cannabis

The use and acceptance of medicinal cannabis continue to evolve, as the growing number of states are permitting the use of specific medical indications. Many countries have legalized marijuana for either medicinal or recreational purposes while some other countries with restricted use. In recent years, a growing number of states in the U.S. have legalized the drug for medical or recreational purposes. With the widespread legalization of cannabis, many companies are also becoming proactive and are taking initiatives for the complete legalization of cannabis.

The legalization of marijuana in different parts of the world can be seen as an effort to increase the additional revenue, this way there will be a boost in the revenue without raising taxes. The legalization of cannabis will allow more consumption of it for medicinal or recreational purposes. Moreover, it will also boost the cannabis business, thus creating more demand for cannabis. Hence, the legalization of cannabis is expected to drive market growth.

Opportunities

Novel product development with increasing R&D activities

Medicinal cannabis comes in many different forms including capsules, chewable gum, creams, crystals, flower, lozenges, oil, and oro-mucosal sprays. High growth in the demand for cannabis with legalization has increased the need to come up with better product strains and delivery systems. This has led many companies to conduct R&D activities to check the genetic improvement strategies for cannabis. The FDA's Cannabis Product Committee (CPC) develops and implements cross-Agency strategies and policies for the regulation of cannabis products. The novel products that are developed and on the rise are hemp protein powders, energy bars, hemp milk, hemp flour, and hemp tea, which are expected to create opportunities for market growth.

Increased adoption of cannabis for recreational purpose

Legalizing recreational marijuana results in helpful regulation of a safe drug, without increasing potential negative consequences. The legalization of marijuana has various societal benefits as the rise in the economy without increasing taxes, creating thousands of job opportunities, stopping the racial differences in marijuana enforcement, and freeing up scarce police resources. Legal recreational marijuana can end the costly enforcement of marijuana laws and debilitate the illegal marijuana market.

Due to these benefits, marijuana has been legalized and is being increasingly adopted by people of different age groups. This creates a demand for good-quality marijuana for fun and relaxation. Hence, the increasing adoption of cannabis for recreational purposes is expected to create opportunities for manufacturers in the market.

Restraint/Challenge

High-cost purchasing and rush for premium quality

Medical cannabis devices can be expensive to manufacture and purchase, and the procedure cost can also be high due to the specialized equipment and training required. This can limit the accessibility of medical cannabis treatments for patients and healthcare facilities, particularly in lower-income regions. Additionally, the high cost of medical cannabis devices and procedures may deter some patients from choosing these treatments, especially if they have to pay out of pocket. Insurance coverage for medical cannabis treatments can also be limited, limiting their adoption.

As a result, the high cost of medical cannabis devices and procedures can be a significant barrier to market growth, especially in regions where cost is a major factor. However, as technology advances, the cost of these devices and procedures may decrease, making them more accessible to patients and healthcare facilities.

The increased intricacy of medical cannabis devices and the high cost of medical cannabis treatment are expected to restrain the market growth.

Recent Development

In May 2018, as per the Cannabis Act of the Government of Canada, the cannabis act will create a strict legal framework for controlling the production, distribution, sale, and possession of cannabis across Canada which is meant to keep cannabis out of the hands of youth and profits out of pockets of organized crime by fostering a robust legal and regulated industry.

Europe Medical Cannabis Market Scope

The Europe medical cannabis market is segmented into nine notable segments based on product, source, species, derivatives, application, route of administration, treatment type, end user, and distribution channel. The growth amongst these segments will help you analyze market growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

Dried Medical Cannabis

Medical Cannabis Capsules

Vape Pen

Whole Flower

Creams & Moisturizer

Ground Flower

Patch

Masks & Serum

Cleanser

Others

On the basis of product, the market is segmented into oil, medical cannabis capsules, patch, whole flower, ground flower, vape pen, dried medical cannabis, creams & moisturizer, masks & serum, cleanser, and others.

Source

Synthetic

Natural

On the basis of source, the market is segmented into synthetic and natural.

Species

Cannabis Indica

Sativa

Hybrid

On the basis of species, the market is segmented into cannabis indica, sativa, and hybrid.

Derivatives

Cannabidiol (CBD)

Tetrahydrocannabinol (THC)/ Delta-8-Tetrahydrocannabinol

Cannabigerol (CBG)

Cannabichromene (CBC)

Cannabinol (CBN)

Cannabicyclol (CBL)

Others

On the basis of derivatives, the market is segmented into Cannabidiol (CBD), tetrahydrocannabinol (THC)/delta-8-tetrahydrocannabinol, Cannabinol (CBN), Cannabicyclol (CBL), Cannabichromene (CBC), Cannabigerol (CBG), and others.

Application

Pain Management

Anxiety

Muscle Spasm

Nausea

Appetite Loss

Eating Disorders

Inflammatory Bowel Diseases

Cancer

Arthritis

Wasting Syndrome (Cachexia)

Alzheimer’s Disease

Epilepsy

Depression and Sleep Disorder

Multiple Sclerosis

Autism

Mental Health Conditions

Elevate Mood

Others

On the basis of application, the market is segmented into Alzheimer’s disease, appetite loss, cancer, inflammatory bowel diseases, eating disorders, epilepsy, autism, mental health conditions, multiple sclerosis, pain management, nausea, muscle spasms, wasting syndrome (cachexia), elevate mood, multiple sclerosis, depression and sleep disorders, anxiety, and others.

Route of Administration

Oral Solutions and Capsules

Smoking

Vaporizers

Topicals

Others

On the basis of route of administration, the market is segmented into oral solutions and capsules, smoking, vaporizers, topicals, and others.

Treatment Type

Analgesic

Psychedelic

Antiviral

Aphrodisiac

Expectorant

Others

On the basis of treatment type, the market is segmented into expectorant, antiviral, analgesic, aphrodisiac, psychedelic, and others.

End User

Homecare Setting

Hospital

Rehab Centers

Pharmaceutical Industry

Research and Development Centers

Others

On the basis of end user, the market is segmented into pharmaceutical industry, research and development centers, homecare settings, hospital, rehab centers, and others.

Distribution Channel

On the basis of distribution channel, the market is segmented into B2B and B2C.

Europe Medical Cannabis Market Regional Analysis/Insights

The countries covered in this market report are Germany, Italy, U.K., Austria, Poland, Lithuania, Ireland, Netherlands, Norway, Switzerland, France, Russia, Spain, Hungary, Belgium, Turkey, and Rest of Europe.

Germany is expected to dominate the Europe medical cannabis market due to the increasing demand for medical cannabis in emerging markets and expansion.

The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Europe Medical Cannabis Market Share Analysis

The Europe medical cannabis market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, regional presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, brand analysis, product approvals, patents, product width and breadth, application dominance, and technology lifeline curve. The above data points provided are only related to the companies’ focus related to the market.

Some of the major market players operating in this market are MediPharm Labs Inc., Tilray, Aurora Cannabis, JAZZ Pharmaceuticals Inc. (GW Pharmaceuticals plc), HEXO Corp. (Zenabis Europe Ltd), Cresco Labs, Peace Naturals Project Inc., CANOPY GROWTH CORPORATION, Medical Marijuana, Inc., Seed Cellar, EcoGen Biosciences, CANNABIS SEEDS USA, Seeds For Me, HUMBOLDT SEED COMPANY, Extractas, World Class Cannabis Seeds (Crop King Seeds), BARNEY'S FARM, FOLIUM BIOSCIENCES, PharmaHemp, Elixinol Europe Limited, ENDOCA, Harmony, MARY’S nutritionals, LLC, Pure Ratios, Greenwich Biosciences, Inc., Upstate Elevator Supply Co., Apothecanna, BOL Pharma, and IDT Australia among others.

SKU-61291

TABLE 1 EUROPE MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 2 EUROPE OIL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 3 EUROPE OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 4 EUROPE OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 5 EUROPE OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 6 EUROPE OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)

TABLE 7 EUROPE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 8 EUROPE DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 9 EUROPE DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 10 EUROPE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 11 EUROPE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 12 EUROPE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 13 EUROPE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 14 EUROPE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 15 EUROPE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 16 EUROPE VAPE PEN IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 17 EUROPE VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 18 EUROPE VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 19 EUROPE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 20 EUROPE WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 21 EUROPE WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 22 EUROPE WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 23 EUROPE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 24 EUROPE CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 25 EUROPE CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 26 EUROPE CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 27 EUROPE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 28 EUROPE GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 29 EUROPE GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 30 EUROPE GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 31 EUROPE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 32 EUROPE PATCH IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 33 EUROPE PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 34 EUROPE PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 35 EUROPE PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 36 EUROPE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 37 EUROPE MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 38 EUROPE MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 39 EUROPE MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 40 EUROPE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 41 EUROPE CLEANSER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 42 EUROPE CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 43 EUROPE CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 44 EUROPE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 45 EUROPE OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 46 EUROPE MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 47 EUROPE SATIVA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 48 EUROPE HYBRID IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 49 EUROPE CANNABIS INDICA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 50 EUROPE MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 51 EUROPE CANNABIDIOL (CBD) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 52 EUROPE TETRAHYDROCANNABINOL (THC)/DELTA-8-TETRAHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 53 EUROPE CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 54 EUROPE CANNABICHROMENE (CBC) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 55 EUROPE CANNABINOL (CBN) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 56 EUROPE CANNABICYCLOL (CBL) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 57 EUROPE OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 58 EUROPE MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 59 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 60 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 61 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 62 EUROPE ANXIETY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 63 EUROPE ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 64 EUROPE MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 65 EUROPE MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 66 EUROPE NAUSEA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 67 EUROPE NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 68 EUROPE APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 69 EUROPE APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 70 EUROPE EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 71 EUROPE EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 72 EUROPE INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 73 EUROPE INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 74 EUROPE CANCER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 75 EUROPE CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 76 EUROPE ARTHRITIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 77 EUROPE ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 78 EUROPE WASHING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 79 EUROPE WASHING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 80 EUROPE ALZHEIMER’S DISEASE IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 81 EUROPE ALZHEIMER’S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 82 EUROPE EPILEPSY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 83 EUROPE EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 84 EUROPE DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 85 EUROPE DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 86 EUROPE MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 87 EUROPE MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 88 EUROPE AUTISM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 89 EUROPE AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 90 EUROPE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 91 EUROPE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 92 EUROPE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 93 EUROPE ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 94 EUROPE ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 95 EUROPE OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 96 EUROPE MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 97 EUROPE ORAL SOLUTIONS AND CAPSULES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 98 EUROPE SMOKING IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 99 EUROPE TOPICALS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 100 EUROPE VAPORIZERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 101 EUROPE OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 102 EUROPE MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 103 EUROPE ANALGESIC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 104 EUROPE PSYCHEDELIC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 105 EUROPE ANTIVIRAL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 106 EUROPE APHRODISIAC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 107 EUROPE EXPECTORANT IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 108 EUROPE OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 109 EUROPE MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 110 EUROPE HOMECARE SETTING IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 111 EUROPE HOSPITAL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 112 EUROPE REHAB CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 113 EUROPE PHARMACEUTICAL INDUSTRY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 114 EUROPE RESEARCH AND DEVELOPMENT CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 115 EUROPE OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 116 EUROPE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 117 EUROPE B2C IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 118 EUROPE B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 119 EUROPE B2B IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 120 EUROPE MEDICAL CANNABIS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)

TABLE 121 EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 122 EUROPE OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 123 EUROPE OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 124 EUROPE OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 125 EUROPE OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 126 EUROPE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 127 EUROPE DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 128 EUROPE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 129 EUROPE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 130 EUROPE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 131 EUROPE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 132 EUROPE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 133 EUROPE VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 134 EUROPE VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 135 EUROPE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 136 EUROPE WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 137 EUROPE WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 138 EUROPE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 139 EUROPE CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 140 EUROPE CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 141 EUROPE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 142 EUROPE GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 143 EUROPE GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 144 EUROPE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 145 EUROPE PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 146 EUROPE PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 147 EUROPE PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 148 EUROPE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 149 EUROPE MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 150 EUROPE MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 151 EUROPE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 152 EUROPE CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 153 EUROPE CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 154 EUROPE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 155 EUROPE MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 156 EUROPE SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 157 EUROPE MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 158 EUROPE MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 159 EUROPE MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 160 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 161 EUROPE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 162 EUROPE ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 163 EUROPE MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 164 EUROPE NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 165 EUROPE APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 166 EUROPE EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 167 EUROPE INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 168 EUROPE CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 169 EUROPE ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 170 EUROPE WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 171 EUROPE ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 172 EUROPE EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 173 EUROPE DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 174 EUROPE MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 175 EUROPE AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 176 EUROPE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 177 EUROPE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 178 EUROPE ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 179 EUROPE MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 180 EUROPE MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 181 EUROPE MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 182 EUROPE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 183 EUROPE B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 184 GERMANY MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 185 GERMANY OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 186 GERMANY OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 187 GERMANY OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 188 GERMANY OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 189 GERMANY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 190 GERMANY DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 191 GERMANY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 192 GERMANY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 193 GERMANY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 194 GERMANY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 195 GERMANY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 196 GERMANY VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 197 GERMANY VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 198 GERMANY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 199 GERMANY WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 200 GERMANY WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 201 GERMANY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 202 GERMANY CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 203 GERMANY CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 204 GERMANY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 205 GERMANY GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 206 GERMANY GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 207 GERMANY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 208 GERMANY PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 209 GERMANY PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 210 GERMANY PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 211 GERMANY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 212 GERMANY MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 213 GERMANY MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 214 GERMANY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 215 GERMANY CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 216 GERMANY CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 217 GERMANY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 218 GERMANY MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 219 GERMANY SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 220 GERMANY MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 221 GERMANY MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 222 GERMANY MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 223 GERMANY PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 224 GERMANY PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 225 GERMANY ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 226 GERMANY MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 227 GERMANY NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 228 GERMANY APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 229 GERMANY EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 230 GERMANY INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 231 GERMANY CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 232 GERMANY ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 233 GERMANY WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 234 GERMANY ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 235 GERMANY EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 236 GERMANY DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 237 GERMANY MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 238 GERMANY AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 239 GERMANY MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 240 GERMANY MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 241 GERMANY ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 242 GERMANY MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 243 GERMANY MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 244 GERMANY MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 245 GERMANY MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 246 GERMANY B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 247 ITALY MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 248 ITALY OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 249 ITALY OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 250 ITALY OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 251 ITALY OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 252 ITALY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 253 ITALY DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 254 ITALY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 255 ITALY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 256 ITALY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 257 ITALY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 258 ITALY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 259 ITALY VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 260 ITALY VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 261 ITALY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 262 ITALY WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 263 ITALY WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 264 ITALY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 265 ITALY CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 266 ITALY CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 267 ITALY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 268 ITALY GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 269 ITALY GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 270 ITALY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 271 ITALY PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 272 ITALY PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 273 ITALY PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 274 ITALY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 275 ITALY MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 276 ITALY MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 277 ITALY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 278 ITALY CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 279 ITALY CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 280 ITALY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 281 ITALY MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 282 ITALY SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 283 ITALY MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 284 ITALY MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 285 ITALY MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 286 ITALY PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 287 ITALY PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 288 ITALY ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 289 ITALY MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 290 ITALY NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 291 ITALY APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 292 ITALY EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 293 ITALY INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 294 ITALY CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 295 ITALY ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 296 ITALY WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 297 ITALY ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 298 ITALY EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 299 ITALY DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 300 ITALY MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 301 ITALY AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 302 ITALY MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 303 ITALY MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 304 ITALY ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 305 ITALY MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 306 ITALY MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 307 ITALY MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 308 ITALY MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 309 ITALY B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 310 U.K. MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 311 U.K. OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 312 U.K. OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 313 U.K. OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 314 U.K. OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 315 U.K. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 316 U.K. DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 317 U.K. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 318 U.K. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 319 U.K. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 320 U.K. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 321 U.K. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 322 U.K. VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 323 U.K. VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 324 U.K. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 325 U.K. WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 326 U.K. WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 327 U.K. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 328 U.K. CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 329 U.K. CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 330 U.K. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 331 U.K. GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 332 U.K. GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 333 U.K. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 334 U.K. PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 335 U.K. PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 336 U.K. PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 337 U.K. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 338 U.K. MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 339 U.K. MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 340 U.K. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 341 U.K. CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 342 U.K. CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 343 U.K. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 344 U.K. MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 345 U.K. SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 346 U.K. MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 347 U.K. MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 348 U.K. MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 349 U.K. PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 350 U.K. PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 351 U.K. ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 352 U.K. MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 353 U.K. NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 354 U.K. APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 355 U.K. EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 356 U.K. INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 357 U.K. CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 358 U.K. ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 359 U.K. WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 360 U.K. ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 361 U.K. EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 362 U.K. DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 363 U.K. MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 364 U.K. AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 365 U.K. MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 366 U.K. MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 367 U.K. ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 368 U.K. MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 369 U.K. MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 370 U.K. MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 371 U.K. MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 372 U.K. B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 373 AUSTRIA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 374 AUSTRIA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 375 AUSTRIA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 376 AUSTRIA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 377 AUSTRIA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 378 AUSTRIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 379 AUSTRIA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 380 AUSTRIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 381 AUSTRIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 382 AUSTRIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 383 AUSTRIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 384 AUSTRIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 385 AUSTRIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 386 AUSTRIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 387 AUSTRIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 388 AUSTRIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 389 AUSTRIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 390 AUSTRIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 391 AUSTRIA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 392 AUSTRIA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 393 AUSTRIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 394 AUSTRIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 395 AUSTRIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 396 AUSTRIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 397 AUSTRIA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 398 AUSTRIA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 399 AUSTRIA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 400 AUSTRIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 401 AUSTRIA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 402 AUSTRIA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 403 AUSTRIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 404 AUSTRIA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 405 AUSTRIA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 406 AUSTRIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 407 AUSTRIA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 408 AUSTRIA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 409 AUSTRIA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 410 AUSTRIA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 411 AUSTRIA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 412 AUSTRIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 413 AUSTRIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 414 AUSTRIA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 415 AUSTRIA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 416 AUSTRIA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 417 AUSTRIA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 418 AUSTRIA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 419 AUSTRIA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 420 AUSTRIA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 421 AUSTRIA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 422 AUSTRIA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 423 AUSTRIA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 424 AUSTRIA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 425 AUSTRIA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 426 AUSTRIA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 427 AUSTRIA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 428 AUSTRIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 429 AUSTRIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 430 AUSTRIA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 431 AUSTRIA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 432 AUSTRIA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 433 AUSTRIA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 434 AUSTRIA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 435 AUSTRIA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 436 POLAND MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 437 POLAND OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 438 POLAND OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 439 POLAND OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 440 POLAND OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 441 POLAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 442 POLAND DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 443 POLAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 444 POLAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 445 POLAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 446 POLAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 447 POLAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 448 POLAND VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 449 POLAND VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 450 POLAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 451 POLAND WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 452 POLAND WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 453 POLAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 454 POLAND CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 455 POLAND CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 456 POLAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 457 POLAND GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 458 POLAND GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 459 POLAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 460 POLAND PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 461 POLAND PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 462 POLAND PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 463 POLAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 464 POLAND MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 465 POLAND MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 466 POLAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 467 POLAND CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 468 POLAND CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 469 POLAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 470 POLAND MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 471 POLAND SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 472 POLAND MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 473 POLAND MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 474 POLAND MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 475 POLAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 476 POLAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 477 POLAND ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 478 POLAND MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 479 POLAND NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 480 POLAND APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 481 POLAND EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 482 POLAND INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 483 POLAND CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 484 POLAND ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 485 POLAND WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 486 POLAND ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 487 POLAND EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 488 POLAND DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 489 POLAND MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 490 POLAND AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 491 POLAND MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 492 POLAND MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 493 POLAND ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 494 POLAND MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 495 POLAND MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 496 POLAND MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 497 POLAND MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 498 POLAND B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 499 LITHUANIA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 500 LITHUANIA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 501 LITHUANIA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 502 LITHUANIA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 503 LITHUANIA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 504 LITHUANIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 505 LITHUANIA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 506 LITHUANIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 507 LITHUANIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 508 LITHUANIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 509 LITHUANIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 510 LITHUANIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 511 LITHUANIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 512 LITHUANIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 513 LITHUANIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 514 LITHUANIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 515 LITHUANIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 516 LITHUANIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 517 LITHUANIA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 518 LITHUANIA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 519 LITHUANIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 520 LITHUANIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 521 LITHUANIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 522 LITHUANIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 523 LITHUANIA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 524 LITHUANIA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 525 LITHUANIA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 526 LITHUANIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 527 LITHUANIA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 528 LITHUANIA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 529 LITHUANIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 530 LITHUANIA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 531 LITHUANIA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 532 LITHUANIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 533 LITHUANIA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 534 LITHUANIA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 535 LITHUANIA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 536 LITHUANIA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 537 LITHUANIA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 538 LITHUANIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 539 LITHUANIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 540 LITHUANIA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 541 LITHUANIA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 542 LITHUANIA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 543 LITHUANIA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 544 LITHUANIA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 545 LITHUANIA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 546 LITHUANIA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 547 LITHUANIA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 548 LITHUANIA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 549 LITHUANIA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 550 LITHUANIA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 551 LITHUANIA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 552 LITHUANIA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 553 LITHUANIA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 554 LITHUANIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 555 LITHUANIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 556 LITHUANIA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 557 LITHUANIA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 558 LITHUANIA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 559 LITHUANIA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 560 LITHUANIA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 561 LITHUANIA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 562 IRELAND MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 563 IRELAND OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 564 IRELAND OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 565 IRELAND OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 566 IRELAND OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 567 IRELAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 568 IRELAND DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 569 IRELAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 570 IRELAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 571 IRELAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 572 IRELAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 573 IRELAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 574 IRELAND VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 575 IRELAND VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 576 IRELAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 577 IRELAND WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 578 IRELAND WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 579 IRELAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 580 IRELAND CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 581 IRELAND CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 582 IRELAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 583 IRELAND GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 584 IRELAND GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 585 IRELAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 586 IRELAND PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 587 IRELAND PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 588 IRELAND PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 589 IRELAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 590 IRELAND MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 591 IRELAND MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 592 IRELAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 593 IRELAND CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 594 IRELAND CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 595 IRELAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 596 IRELAND MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 597 IRELAND SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 598 IRELAND MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 599 IRELAND MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 600 IRELAND MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 601 IRELAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 602 IRELAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 603 IRELAND ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 604 IRELAND MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 605 IRELAND NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 606 IRELAND APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 607 IRELAND EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 608 IRELAND INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 609 IRELAND CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 610 IRELAND ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 611 IRELAND WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 612 IRELAND ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 613 IRELAND EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 614 IRELAND DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 615 IRELAND MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 616 IRELAND AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 617 IRELAND MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 618 IRELAND MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 619 IRELAND ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 620 IRELAND MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 621 IRELAND MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 622 IRELAND MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 623 IRELAND MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 624 IRELAND B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 625 NETHERLANDS MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 626 NETHERLANDS OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 627 NETHERLANDS OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 628 NETHERLANDS OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 629 NETHERLANDS OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 630 NETHERLANDS BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 631 NETHERLANDS DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 632 NETHERLANDS MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 633 NETHERLANDS MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 634 NETHERLANDS MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 635 NETHERLANDS MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 636 NETHERLANDS BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 637 NETHERLANDS VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 638 NETHERLANDS VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 639 NETHERLANDS BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 640 NETHERLANDS WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 641 NETHERLANDS WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 642 NETHERLANDS BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 643 NETHERLANDS CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 644 NETHERLANDS CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 645 NETHERLANDS BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 646 NETHERLANDS GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 647 NETHERLANDS GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 648 NETHERLANDS BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 649 NETHERLANDS PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 650 NETHERLANDS PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 651 NETHERLANDS PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 652 NETHERLANDS BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 653 NETHERLANDS MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 654 NETHERLANDS MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 655 NETHERLANDS BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 656 NETHERLANDS CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 657 NETHERLANDS CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 658 NETHERLANDS BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 659 NETHERLANDS MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 660 NETHERLANDS SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 661 NETHERLANDS MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 662 NETHERLANDS MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 663 NETHERLANDS MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 664 NETHERLANDS PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 665 NETHERLANDS PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 666 NETHERLANDS ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 667 NETHERLANDS MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 668 NETHERLANDS NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 669 NETHERLANDS APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 670 NETHERLANDS EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 671 NETHERLANDS INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 672 NETHERLANDS CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 673 NETHERLANDS ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 674 NETHERLANDS WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 675 NETHERLANDS ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 676 NETHERLANDS EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 677 NETHERLANDS DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 678 NETHERLANDS MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 679 NETHERLANDS AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 680 NETHERLANDS MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 681 NETHERLANDS MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 682 NETHERLANDS ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 683 NETHERLANDS MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 684 NETHERLANDS MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 685 NETHERLANDS MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 686 NETHERLANDS MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 687 NETHERLANDS B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 688 NORWAY MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 689 NORWAY OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 690 NORWAY OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 691 NORWAY OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 692 NORWAY OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 693 NORWAY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 694 NORWAY DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 695 NORWAY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 696 NORWAY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 697 NORWAY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 698 NORWAY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 699 NORWAY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 700 NORWAY VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 701 NORWAY VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 702 NORWAY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 703 NORWAY WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 704 NORWAY WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 705 NORWAY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 706 NORWAY CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 707 NORWAY CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 708 NORWAY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 709 NORWAY GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 710 NORWAY GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 711 NORWAY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 712 NORWAY PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 713 NORWAY PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 714 NORWAY PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 715 NORWAY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 716 NORWAY MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 717 NORWAY MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 718 NORWAY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 719 NORWAY CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 720 NORWAY CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 721 NORWAY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 722 NORWAY MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 723 NORWAY SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 724 NORWAY MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 725 NORWAY MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 726 NORWAY MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 727 NORWAY PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 728 NORWAY PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 729 NORWAY ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 730 NORWAY MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 731 NORWAY NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 732 NORWAY APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 733 NORWAY EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 734 NORWAY INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 735 NORWAY CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 736 NORWAY ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 737 NORWAY WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 738 NORWAY ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 739 NORWAY EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 740 NORWAY DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 741 NORWAY MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 742 NORWAY AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 743 NORWAY MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 744 NORWAY MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 745 NORWAY ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 746 NORWAY MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 747 NORWAY MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 748 NORWAY MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 749 NORWAY MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 750 NORWAY B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 751 SWITZERLAND MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 752 SWITZERLAND OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 753 SWITZERLAND OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 754 SWITZERLAND OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 755 SWITZERLAND OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 756 SWITZERLAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 757 SWITZERLAND DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 758 SWITZERLAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 759 SWITZERLAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 760 SWITZERLAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 761 SWITZERLAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 762 SWITZERLAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 763 SWITZERLAND VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 764 SWITZERLAND VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 765 SWITZERLAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 766 SWITZERLAND WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 767 SWITZERLAND WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 768 SWITZERLAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 769 SWITZERLAND CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 770 SWITZERLAND CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 771 SWITZERLAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 772 SWITZERLAND GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 773 SWITZERLAND GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 774 SWITZERLAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 775 SWITZERLAND PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 776 SWITZERLAND PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 777 SWITZERLAND PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 778 SWITZERLAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 779 SWITZERLAND MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 780 SWITZERLAND MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 781 SWITZERLAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 782 SWITZERLAND CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 783 SWITZERLAND CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 784 SWITZERLAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 785 SWITZERLAND MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 786 SWITZERLAND SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 787 SWITZERLAND MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 788 SWITZERLAND MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 789 SWITZERLAND MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 790 SWITZERLAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 791 SWITZERLAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 792 SWITZERLAND ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 793 SWITZERLAND MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 794 SWITZERLAND NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 795 SWITZERLAND APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 796 SWITZERLAND EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 797 SWITZERLAND INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 798 SWITZERLAND CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 799 SWITZERLAND ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 800 SWITZERLAND WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 801 SWITZERLAND ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 802 SWITZERLAND EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 803 SWITZERLAND DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 804 SWITZERLAND MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 805 SWITZERLAND AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 806 SWITZERLAND MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 807 SWITZERLAND MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 808 SWITZERLAND ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 809 SWITZERLAND MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 810 SWITZERLAND MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 811 SWITZERLAND MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 812 SWITZERLAND MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 813 SWITZERLAND B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 814 FRANCE MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 815 FRANCE OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 816 FRANCE OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 817 FRANCE OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 818 FRANCE OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 819 FRANCE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 820 FRANCE DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 821 FRANCE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 822 FRANCE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 823 FRANCE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 824 FRANCE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 825 FRANCE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 826 FRANCE VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 827 FRANCE VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 828 FRANCE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 829 FRANCE WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 830 FRANCE WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 831 FRANCE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 832 FRANCE CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 833 FRANCE CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 834 FRANCE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 835 FRANCE GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 836 FRANCE GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 837 FRANCE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 838 FRANCE PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 839 FRANCE PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 840 FRANCE PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 841 FRANCE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 842 FRANCE MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 843 FRANCE MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 844 FRANCE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 845 FRANCE CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 846 FRANCE CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 847 FRANCE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 848 FRANCE MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 849 FRANCE SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 850 FRANCE MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 851 FRANCE MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 852 FRANCE MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 853 FRANCE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 854 FRANCE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 855 FRANCE ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 856 FRANCE MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 857 FRANCE NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 858 FRANCE APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 859 FRANCE EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 860 FRANCE INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 861 FRANCE CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 862 FRANCE ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 863 FRANCE WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 864 FRANCE ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 865 FRANCE EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 866 FRANCE DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 867 FRANCE MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 868 FRANCE AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 869 FRANCE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 870 FRANCE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 871 FRANCE ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 872 FRANCE MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 873 FRANCE MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 874 FRANCE MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 875 FRANCE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 876 FRANCE B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 877 RUSSIA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 878 RUSSIA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 879 RUSSIA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 880 RUSSIA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 881 RUSSIA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 882 RUSSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 883 RUSSIA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 884 RUSSIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 885 RUSSIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 886 RUSSIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 887 RUSSIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 888 RUSSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 889 RUSSIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 890 RUSSIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 891 RUSSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 892 RUSSIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 893 RUSSIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 894 RUSSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 895 RUSSIA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 896 RUSSIA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 897 RUSSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 898 RUSSIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 899 RUSSIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 900 RUSSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 901 RUSSIA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 902 RUSSIA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 903 RUSSIA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 904 RUSSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 905 RUSSIA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 906 RUSSIA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 907 RUSSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 908 RUSSIA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 909 RUSSIA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 910 RUSSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 911 RUSSIA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 912 RUSSIA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 913 RUSSIA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 914 RUSSIA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 915 RUSSIA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 916 RUSSIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 917 RUSSIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 918 RUSSIA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 919 RUSSIA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 920 RUSSIA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 921 RUSSIA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 922 RUSSIA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 923 RUSSIA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 924 RUSSIA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 925 RUSSIA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 926 RUSSIA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 927 RUSSIA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 928 RUSSIA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 929 RUSSIA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 930 RUSSIA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 931 RUSSIA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 932 RUSSIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 933 RUSSIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 934 RUSSIA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 935 RUSSIA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 936 RUSSIA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 937 RUSSIA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 938 RUSSIA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 939 RUSSIA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 940 SPAIN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 941 SPAIN OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 942 SPAIN OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 943 SPAIN OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 944 SPAIN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 945 SPAIN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 946 SPAIN DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 947 SPAIN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 948 SPAIN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 949 SPAIN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 950 SPAIN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 951 SPAIN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 952 SPAIN VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 953 SPAIN VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 954 SPAIN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 955 SPAIN WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 956 SPAIN WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 957 SPAIN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 958 SPAIN CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 959 SPAIN CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 960 SPAIN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 961 SPAIN GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 962 SPAIN GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 963 SPAIN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 964 SPAIN PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 965 SPAIN PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 966 SPAIN PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 967 SPAIN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 968 SPAIN MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 969 SPAIN MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 970 SPAIN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 971 SPAIN CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 972 SPAIN CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 973 SPAIN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 974 SPAIN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 975 SPAIN SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 976 SPAIN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 977 SPAIN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 978 SPAIN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 979 SPAIN PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 980 SPAIN PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 981 SPAIN ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 982 SPAIN MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 983 SPAIN NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 984 SPAIN APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 985 SPAIN EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 986 SPAIN INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 987 SPAIN CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 988 SPAIN ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 989 SPAIN WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 990 SPAIN ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 991 SPAIN EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 992 SPAIN DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 993 SPAIN MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 994 SPAIN AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 995 SPAIN MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 996 SPAIN MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 997 SPAIN ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 998 SPAIN MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 999 SPAIN MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 1000 SPAIN MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 1001 SPAIN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 1002 SPAIN B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 1003 HUNGARY MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 1004 HUNGARY OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1005 HUNGARY OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 1006 HUNGARY OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1007 HUNGARY OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1008 HUNGARY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1009 HUNGARY DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 1010 HUNGARY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1011 HUNGARY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 1012 HUNGARY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1013 HUNGARY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1014 HUNGARY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1015 HUNGARY VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1016 HUNGARY VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1017 HUNGARY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1018 HUNGARY WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1019 HUNGARY WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1020 HUNGARY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1021 HUNGARY CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1022 HUNGARY CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1023 HUNGARY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1024 HUNGARY GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1025 HUNGARY GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1026 HUNGARY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1027 HUNGARY PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1028 HUNGARY PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1029 HUNGARY PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1030 HUNGARY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1031 HUNGARY MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1032 HUNGARY MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1033 HUNGARY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1034 HUNGARY CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1035 HUNGARY CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1036 HUNGARY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1037 HUNGARY MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 1038 HUNGARY SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 1039 HUNGARY MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1040 HUNGARY MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 1041 HUNGARY MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1042 HUNGARY PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1043 HUNGARY PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 1044 HUNGARY ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1045 HUNGARY MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1046 HUNGARY NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1047 HUNGARY APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1048 HUNGARY EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1049 HUNGARY INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1050 HUNGARY CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1051 HUNGARY ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1052 HUNGARY WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1053 HUNGARY ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1054 HUNGARY EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1055 HUNGARY DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1056 HUNGARY MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1057 HUNGARY AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1058 HUNGARY MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1059 HUNGARY MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 1060 HUNGARY ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1061 HUNGARY MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 1062 HUNGARY MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 1063 HUNGARY MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 1064 HUNGARY MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 1065 HUNGARY B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 1066 BELGIUM MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 1067 BELGIUM OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1068 BELGIUM OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 1069 BELGIUM OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1070 BELGIUM OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1071 BELGIUM BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1072 BELGIUM DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 1073 BELGIUM MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1074 BELGIUM MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 1075 BELGIUM MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1076 BELGIUM MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1077 BELGIUM BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1078 BELGIUM VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1079 BELGIUM VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1080 BELGIUM BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1081 BELGIUM WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1082 BELGIUM WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1083 BELGIUM BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1084 BELGIUM CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1085 BELGIUM CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1086 BELGIUM BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1087 BELGIUM GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1088 BELGIUM GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1089 BELGIUM BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1090 BELGIUM PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1091 BELGIUM PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1092 BELGIUM PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1093 BELGIUM BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1094 BELGIUM MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1095 BELGIUM MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1096 BELGIUM BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1097 BELGIUM CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1098 BELGIUM CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1099 BELGIUM BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1100 BELGIUM MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 1101 BELGIUM SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 1102 BELGIUM MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1103 BELGIUM MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 1104 BELGIUM MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1105 BELGIUM PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1106 BELGIUM PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 1107 BELGIUM ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1108 BELGIUM MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1109 BELGIUM NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1110 BELGIUM APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1111 BELGIUM EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1112 BELGIUM INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1113 BELGIUM CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1114 BELGIUM ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1115 BELGIUM WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1116 BELGIUM ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1117 BELGIUM EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1118 BELGIUM DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1119 BELGIUM MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1120 BELGIUM AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1121 BELGIUM MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1122 BELGIUM MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 1123 BELGIUM ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1124 BELGIUM MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 1125 BELGIUM MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 1126 BELGIUM MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 1127 BELGIUM MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 1128 BELGIUM B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 1129 TURKEY MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 1130 TURKEY OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1131 TURKEY OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 1132 TURKEY OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1133 TURKEY OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1134 TURKEY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1135 TURKEY DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 1136 TURKEY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1137 TURKEY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)

TABLE 1138 TURKEY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1139 TURKEY MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1140 TURKEY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1141 TURKEY VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1142 TURKEY VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1143 TURKEY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1144 TURKEY WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1145 TURKEY WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1146 TURKEY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1147 TURKEY CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1148 TURKEY CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1149 TURKEY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1150 TURKEY GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1151 TURKEY GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1152 TURKEY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1153 TURKEY PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1154 TURKEY PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1155 TURKEY PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1156 TURKEY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1157 TURKEY MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1158 TURKEY MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1159 TURKEY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1160 TURKEY CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1161 TURKEY CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1162 TURKEY BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)

TABLE 1163 TURKEY MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 1164 TURKEY SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)

TABLE 1165 TURKEY MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)

TABLE 1166 TURKEY MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)

TABLE 1167 TURKEY MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1168 TURKEY PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1169 TURKEY PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 1170 TURKEY ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1171 TURKEY MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1172 TURKEY NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1173 TURKEY APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1174 TURKEY EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1175 TURKEY INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1176 TURKEY CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1177 TURKEY ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1178 TURKEY WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1179 TURKEY ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1180 TURKEY EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1181 TURKEY DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1182 TURKEY MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1183 TURKEY AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1184 TURKEY MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 1185 TURKEY MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 1186 TURKEY ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 1187 TURKEY MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)

TABLE 1188 TURKEY MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)

TABLE 1189 TURKEY MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 1190 TURKEY MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 1191 TURKEY B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 1192 REST OF EUROPE MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

At what growth rate will the market be projected to grow during the forecast period of 2023 to 2030?

The Europe Medical Cannabis Market is projected to grow at a CAGR of 22.5% during the forecast period by 2030.

Who are the major players operating in the market?

The significant factors flourishing the growth of the Europe Medical cannabis Market are Tilray, Medipharm Labs, Althea Company Pty Ltd, PharmaHemp, Aurora Cannabis., Elixinol Global Limited, CANOPY GROWTH CORPORATION, Jazz Pharmaceuticals, Inc., ECOGEN BIOSCIENCES, Little Green Pharma, GRASS & CO., CANNARAY, Sanity Group GmbH., VIVO Cannabis Inc., HEXO Corp., and Marrican Inc.

What are the major countries covered in the Market?

The major countries covered in the Europe Medical cannabis Market are Germany, France, U.K., Spain, Italy, Netherlands, Belgium, Russia, Switzerland and Rest of Europe.

What are the significant factors flourishing the growth of the market?

The significant factors flourishing the growth of the Europe Medical cannabis Market are Rise in Geriatric Population, and Novel Product Development with Increasing Research and Development (R & D) Activities.

BROWSE RELATED Press Release

Increased use of Cannabis in Medicines is Expected to Drive the Demand for the Global Medical Cannabis Market

Tilray, Aurora Cannabis, and CANOPY GROWTH CORPORATION, are Dominating the Thailand Medical Cannabis Market in 2021

Tilray, Jazz Pharmaceuticals, Inc., Aurora Cannabis Inc. are dominating the Europe Medical Cannabis Market in 2021

Free Sample Report

CHOOSE LICENCE TYPE

Enterprise User 4200.00
Single User 3500.00
DBMR Factbook 2000.00
DBMR Prime 5500.00
DBMR Supreme 7500.00

Buy Now

Request for TOC Speak to Analyst Inquire Before Buying Free Sample Report

Advance Formative Research Customization Request for bulk Reports

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Pharmaceutical

Europe Medical Cannabis Market – Industry Trends and Forecast to 2030

Europe Medical Cannabis Market Analysis and Insights

Europe Medical Cannabis Market Dynamics

Europe Medical Cannabis Market Scope

Europe Medical Cannabis Market Regional Analysis/Insights

Competitive Landscape and Europe Medical Cannabis Market Share Analysis

Please fill in the below form for Infographics

Research Methodology:

Please fill in the below form for Research Methodology

Customization Available:

Please fill in the below form for Available Customization

FREQUENTLY ASK QUESTIONS

BROWSE RELATED REPORTS

BROWSE RELATED Blogs

BROWSE RELATED Press Release

CHOOSE LICENCE TYPE

Why Choose Us

Industry Coverage

Regional Coverage

Technology Coverage

Goal Oriented Solutions

Unparallel Analyst Support

Client Testimonials

David Manning - Thermo Fisher Scientific

Manager - Market Analytics,

Business Development Manager,

Business Intelligence and Analytics,

Competition Analyst,

Marketing Director,

COO,

Marketing Director,

Product manager,

Investor relations,

Market Analyst,

Andrew - Senior Global Marketing Manager,

Amarildo - Manager, Global Strategic Alignment

Tor Hammer

Tommaso Finocchiaro

Yuki Kopyl (Asian Business Development Department)

Share Your Experience With Us

Follow Us on

Reports

Market Insights

Support

Solutions

Suggested Searches

Share Your
Experience With Us